COROMANDEL.NS
Coromandel International Limited [COROMANDEL.NS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
COROMANDEL.NS Stock Summary
Top 10 Correlated ETFs
COROMANDEL.NS
Top 10 Correlated Stocks
COROMANDEL.NS
In the News
COROMANDEL.NS Financial details
Company Rating
Buy
Market Cap
340.14B
Income
14.81B
Revenue
88.99B
Book val./share
-
Cash/share
-
Dividend
12
Dividend %
1.03%
Employees
5.06K
Optionable
No
Shortable
Yes
Earnings
13 May 2024
P/E
19.35
Forward P/E
16.94
PEG
-57.27
P/S
2.93
P/B
3.79
P/C
-
P/FCF
4461.1
Quick Ratio
1.31
Current Ratio
2.23
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
50.33
EPS next Y
67.11
EPS next Q
-
EPS this Y
31.52%
EPS next Y
33.34%
EPS next 5Y
45.22%
EPS last 5Y
22.69%
Revenue last 5Y
8.45%
Revenue Q/Q
-21.81%
EPS Q/Q
-69.48%
-
-
-
-
SMA20
4.74%
SMA50
3.7%
SMA100
3.23%
Inst Own
0.11%
Inst Trans
1%
ROA
12%
ROE
42%
ROC
0.3%
Gross Margin
-74%
Oper. Margin
24%
Profit Margin
15%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
908.1-1271.55
52W High
-10.54%
52W Low
+25.23%
RSI
57
Rel Volume
1.41
Avg Volume
435.12K
Volume
613.6K
Perf Week
-0.7%
Perf Month
5.65%
Perf Quarter
2.4%
Perf Half Y
-1.52%
-
-
-
-
Beta
0.4
-
-
Volatility
10.66%, 34.84%
Prev Close
0.28%
Price
1137.05
Change
-0.43%
COROMANDEL.NS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
| Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 344.73 | 337.02 | 369.67 | 419.97 | 514.7 | |
| Net income per share | 24.64 | 36.4 | 45.34 | 52.09 | 68.51 | |
| Operating cash flow per share | 18 | 63.63 | 141.56 | 70.82 | 20.11 | |
| Free cash flow per share | 8.66 | 54.88 | 134.91 | 61.35 | -0.49 | |
| Cash per share | 4.52 | 5.17 | 25.88 | 58.97 | 47.44 | |
| Book value per share | 114.85 | 147.55 | 175.69 | 216.68 | 269.14 | |
| Tangible book value per share | 112.74 | 146.77 | 174.9 | 215.69 | 268.04 | |
| Share holders equity per share | 114.85 | 147.55 | 175.69 | 216.68 | 269.14 | |
| Interest debt per share | 109.57 | 76.81 | 16.49 | 15.77 | 19.46 | |
| Market cap | 145.07B | 159.83B | 227.07B | 234.63B | 258.34B | |
| Enterprise value | 173.29B | 179.52B | 224B | 231.52B | 248.33B | |
| P/E ratio | 20.14 | 15.01 | 17.08 | 15.35 | 12.83 | |
| Price to sales ratio | 1.44 | 1.62 | 2.1 | 1.9 | 1.71 | |
| POCF ratio | 27.56 | 8.58 | 5.47 | 11.29 | 43.71 | |
| PFCF ratio | 57.26 | 9.95 | 5.74 | 13.03 | -1.81K | |
| P/B Ratio | 4.32 | 3.7 | 4.41 | 3.69 | 3.27 | |
| PTB ratio | 4.32 | 3.7 | 4.41 | 3.69 | 3.27 | |
| EV to sales | 1.72 | 1.82 | 2.07 | 1.88 | 1.64 | |
| Enterprise value over EBITDA | 11.68 | 10.09 | 10.88 | 10.1 | 8.14 | |
| EV to operating cash flow | 32.92 | 9.64 | 5.4 | 11.14 | 42.02 | |
| EV to free cash flow | 68.4 | 11.18 | 5.66 | 12.86 | -1.74K | |
| Earnings yield | 0.05 | 0.07 | 0.06 | 0.07 | 0.08 | |
| Free cash flow yield | 0.02 | 0.1 | 0.17 | 0.08 | 0 | |
| Debt to equity | 0.88 | 0.47 | 0.07 | 0.06 | 0.05 | |
| Debt to assets | 0.28 | 0.2 | 0.04 | 0.03 | 0.03 | |
| Net debt to EBITDA | 1.9 | 1.11 | -0.15 | -0.14 | -0.33 | |
| Current ratio | 1.24 | 1.45 | 1.98 | 1.87 | 1.75 | |
| Interest coverage | 6.11 | 7.44 | 18.96 | 30.16 | 16.24 | |
| Income quality | 0.48 | 1.35 | 2.32 | 1.01 | 0.22 | |
| Dividend Yield | 0.02 | 0.01 | 0.02 | 0.02 | 0.01 | |
| Payout ratio | 0.32 | 0.12 | 0.4 | 0.23 | 0.18 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.01 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | -0.52 | -0.14 | -0.05 | -0.13 | -1.02 | |
| Capex to revenue | -0.03 | -0.03 | -0.02 | -0.02 | -0.04 | |
| Capex to depreciation | -2.4 | -1.62 | -1.13 | -1.61 | -3.33 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 252.32 | 347.61 | 423.34 | 503.94 | 644.11 | |
| ROIC | 0.15 | 0.2 | 0.23 | 0.21 | 0.25 | |
| Return on tangible assets | 0.07 | 0.11 | 0.15 | 0.14 | 0.14 | |
| Graham Net | -58.42 | -23.59 | 20.22 | 15.45 | 9.67 | |
| Working capital | 16.74B | 24.27B | 32.19B | 38.75B | 43.87B | |
| Tangible asset value | 32.97B | 42.95B | 51.28B | 63.29B | 78.75B | |
| Net current asset value | 15.37B | 19.63B | 27.76B | 34.14B | 39.17B | |
| Invested capital | 0.88 | 0.47 | 0.07 | 0.06 | 0.05 | |
| Average receivables | 49.47B | 49.3B | 39.46B | 27.31B | 32.18B | |
| Average payables | 29.27B | 35.55B | 31.35B | 34.18B | 46.14B | |
| Average inventory | 27.34B | 29.69B | 26.49B | 31.32B | 40.4B | |
| Days sales outstanding | 181.24 | 179.66 | 102.33 | 71.79 | 96.83 | |
| Days payables outstanding | 145.41 | 133.68 | 108.82 | 99.44 | 81.94 | |
| Days of inventory on hand | 125.27 | 107.69 | 96.86 | 93.08 | 68.1 | |
| Receivables turnover | 2.01 | 2.03 | 3.57 | 5.08 | 3.77 | |
| Payables turnover | 2.51 | 2.73 | 3.35 | 3.67 | 4.45 | |
| Inventory turnover | 2.91 | 3.39 | 3.77 | 3.92 | 5.36 | |
| ROE | 0.21 | 0.25 | 0.26 | 0.24 | 0.25 | |
| Capex per share | -9.34 | -8.75 | -6.65 | -9.47 | -20.6 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q3
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 282.64 | -307.11 | 186.22 | 237.47 | 185.6 | |
| Net income per share | 17.92 | 8.38 | 8.38 | 25.72 | 7.85 | |
| Operating cash flow per share | 3.2 | 0.26 | 3.27 | 3.67 | 4.32 | |
| Free cash flow per share | 3.2 | 0.26 | 3.27 | 3.67 | 4.32 | |
| Cash per share | 20.66 | 47.41 | 47.4 | 121.61 | 0 | |
| Book value per share | 252.55 | 268.96 | 268.93 | 307.9 | 0 | |
| Tangible book value per share | 0 | 267.86 | 0 | 296.95 | 0 | |
| Share holders equity per share | 252.55 | 268.96 | 268.93 | 307.9 | 0 | |
| Interest debt per share | 1.93 | 14.77 | 1.78 | 16.39 | 1.29 | |
| Market cap | 260.82B | 258.51B | 278.87B | 337.33B | 367.31B | |
| Enterprise value | 266.9B | 248.5B | 292.81B | 329.52B | 367.31B | |
| P/E ratio | 12.38 | 26.22 | 28.29 | 11.14 | 39.76 | |
| Price to sales ratio | 3.14 | -2.86 | 5.09 | 4.83 | 6.72 | |
| POCF ratio | 277 | 3.35K | 289.89 | 312.63 | 289.09 | |
| PFCF ratio | 277 | 3.35K | 289.89 | 312.63 | 289.09 | |
| P/B Ratio | 3.51 | 3.27 | 3.53 | 3.72 | 0 | |
| PTB ratio | 3.51 | 3.27 | 3.53 | 3.72 | 0 | |
| EV to sales | 3.21 | -2.75 | 5.35 | 4.72 | 6.72 | |
| Enterprise value over EBITDA | 32.94 | 58.8 | 67.55 | 29.96 | 90.16 | |
| EV to operating cash flow | 283.45 | 3.22K | 304.37 | 305.39 | 289.09 | |
| EV to free cash flow | 283.45 | 3.22K | 304.37 | 305.39 | 289.09 | |
| Earnings yield | 0.02 | 0.01 | 0.01 | 0.02 | 0.01 | |
| Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
| Debt to equity | 0 | 0.05 | 0 | 0.05 | 0 | |
| Debt to assets | 0 | 0.03 | 0 | 0.03 | 0 | |
| Net debt to EBITDA | 0.75 | -2.37 | 3.22 | -0.71 | 0 | |
| Current ratio | 0 | 1.75 | 0 | 2.23 | 0 | |
| Interest coverage | 13.43 | 9.1 | 12.62 | 22.63 | 9.02 | |
| Income quality | 0.18 | 0.03 | 0.19 | 0.14 | 0.55 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0.02 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 319.11 | 225.22 | 225.2 | 422.12 | 0 | |
| ROIC | 0.08 | 0.03 | 0.06 | 0.08 | 0 | |
| Return on tangible assets | 0 | 0.02 | 0 | 0.05 | 0 | |
| Graham Net | 20.66 | 9.66 | 47.4 | 67.47 | 0 | |
| Working capital | 6.07B | 43.87B | 13.94B | 58.98B | 0 | |
| Tangible asset value | 0 | 78.75B | 0 | 87.39B | 0 | |
| Net current asset value | 6.07B | 39.17B | 13.94B | 53.91B | 0 | |
| Invested capital | 0 | 0.05 | 0 | 0.05 | 0 | |
| Average receivables | 4.15B | 20.06B | 20.06B | 13.46B | 13.46B | |
| Average payables | 35.61B | 26.57B | 26.57B | 21.06B | 21.06B | |
| Average inventory | 24.96B | 22.08B | 22.08B | 16.87B | 16.87B | |
| Days sales outstanding | 0 | -39.99 | 0 | 34.67 | 0 | |
| Days payables outstanding | 0 | 107.82 | 0 | 74.08 | 0 | |
| Days of inventory on hand | 0 | 89.62 | 0 | 59.34 | 0 | |
| Receivables turnover | 0 | -2.25 | 0 | 2.6 | 0 | |
| Payables turnover | 0 | 0.83 | 0 | 1.21 | 0 | |
| Inventory turnover | 0 | 1 | 0 | 1.52 | 0 | |
| ROE | 0.07 | 0.03 | 0.03 | 0.08 | 0 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
COROMANDEL.NS Frequently Asked Questions
What is Coromandel International Limited stock symbol ?
Coromandel International Limited is a IN stock and trading under the symbol COROMANDEL.NS
What is Coromandel International Limited stock quote today ?
Coromandel International Limited stock price is $1137.05 today.
Is Coromandel International Limited stock public?
Yes, Coromandel International Limited is a publicly traded company.
Something similar
Company Profile
- Volume Average 435.12K
- Market Capitalization 340.14B
- Employee 5.06K
- CEO Mr. Arun Alagappan
- Headquarters Secunderabad,IN
- IPO Date 2002-08-12
-
Website
https://www.coromandel.biz 
Coromandel International Limited engages in the manufacture and sale of farm inputs in India. The company operates in two segments, Nutrient and Other Allied Business; and Crop Protection. It offers phosphatic and other fertilizers; bio pesticide solutions; single super phosphates; crop protection products, including insecticides, fungicides, herbicides, and bio products, as well as plant growth regulators; specialty nutrients, such as bentonite sulphur, water-soluble and liquid fertilizers, and micronutrients; and organic nutri-booster solutions. The company also provides farming services, such as crop advisory, soil testing, and farm mechanization. In addition, it operates approximately 750 rural retail outlets in Andhra Pradesh, Telangana, and Karnataka. The company also exports its products. The company was formerly known as Coromandel Fertilisers Ltd and changed its name to Coromandel International Limited in September 2009. The company was incorporated in 1961 and is based in Secunderabad, India. Coromandel International Limited is a subsidiary of E.I.D.-Parry (India) Limited.
